Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

Inclusion Criteria

• •Confirmed or suspected diagnosis of Crohn's disease based on standardized diagnostic criteria. The enrollment should occur within 30 days of diagnosis.
• •Able to provide written informed consent or the ability to obtain written informed consent from the parents or patient's legal guardian in conjunction with youth assent.
• •Consented to have specimens tested for genetics and immune responses.
• •Access to follow-up data for a minimum of 36 months after diagnosis.
• •Final eligibility will be determined by the health professionals conducting this clinical trial.